亨迪药业 (301211.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(亨迪药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 138,059,120.72663,025,874.35542,445,746.24405,758,580.58193,286,953.47514,911,768.91345,656,815.72240,376,159.14128,246,403.15
 营业利润(元) 44,340,764.81205,334,070.12171,168,058.78133,790,701.8848,111,805.96148,725,918.4693,606,855.4765,409,669.5133,845,523.10
 利润总额(元) 44,323,592.98202,816,100.34170,786,541.22133,645,437.1047,938,084.65147,442,382.0393,563,864.6065,355,888.1733,742,621.48
 净利润(元) 37,381,597.20176,116,201.67144,514,979.02113,038,868.4139,922,932.84125,723,912.4278,551,187.1154,398,917.2327,964,503.94
 归属于母公司股东的净利润(元) 37,381,597.20176,116,201.67144,514,979.02113,038,868.4139,922,932.84125,723,912.4278,551,187.1154,398,917.2327,964,503.94
盈利能力:
 销售毛利率(%) 37.9240.1740.7539.4032.2228.8829.5028.8229.76
 销售净利率(%) 27.0826.5626.6427.8620.6524.4222.7322.6321.81
 净资产收益率(%) 1.597.606.344.951.75----
 总资产报酬率ROA(%) 1.066.035.464.331.50----
 投入资本回报率ROIC(%) 1.577.596.254.931.745.593.532.421.25
营运能力:
 存货周转率(次) 0.592.752.802.051.23----
 应收账款周转率(次) 1.9610.687.454.422.21----
 总资产周转率(次) 0.050.260.230.170.08----
偿债能力:
 资产负债率(%) 5.807.466.897.946.618.863.624.414.67
 股东权益比率(%) 94.2092.5493.1192.0693.3991.1496.3895.5995.33
 已获利息倍数(倍) -1.50-3.01-3.35-3.74-3.13-1.26-0.86-0.94-1.45
 流动比率 15.4711.9813.2611.5414.4910.6626.4221.7120.44
 速动比率 14.1410.9112.3110.7313.4510.0224.9920.4619.41
发展能力:
 营业收入增长率(%) -28.5728.7656.9368.8050.72-4.76-17.38-13.176.01
 营业利润增长率(%) -7.8438.0682.86104.5442.156.78-18.18-14.28-14.91
 税后利润增长率(%) -6.3740.0083.98107.8042.763.35-20.94-20.00-23.45
 净资产增长率(%) 3.373.524.370.762.932.42178.75196.36205.42
 总资产增长率(%) 2.481.918.034.635.077.18155.67176.34185.21

前瞻产业研究院